Medical and scientific communications are evolving, and biopharma organizations are facing new challenges that extend beyond traditional commercial marketing. In this conversation, Eugene Lee, group president of specialty communications at CMI Media Group, explains why the company launched a dedicated specialty communications business unit focused on medical affairs and scientific engagement.
Lee discusses how medical affairs is emerging as an increasingly important pillar within biopharma organizations and why new approaches are needed to connect scientific education with measurable outcomes. He shares his perspective on building compliant omnichannel communications programs, including how organizations can evaluate the impact of scientific education through signals such as diagnosis and testing activity.
The discussion also explores the growing role of artificial intelligence in medical communications. Lee explains how AI can help process large volumes of real-world evidence, accelerate analysis and generate insights that support faster, more informed omnichannel decision-making while operating within compliance requirements.
The editorial staff had no role in this post's creation.